Brief: Extended Tissue Establishment Authorization
28/06/2018 07:43
NextCell Pharma AB NXTCL.TE :
* EXTENDED TISSUE ESTABLISHMENT AUTHORIZATION
* RECEIVED INSPECTION REPORT THAT AUTHORIZES BUSINESS TO
CONTINUE
WITHOUT ANY CHANGES BEING REQUIRED.
Source text for Eikon: ID:nWkr55RFWL
Further company coverage: NXTCL.TE
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln